Viewing nowTelmisartan 80 mg Tablets (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

MFDS item code 201301695 · Approved 2013.01.22 · Insurance code 658602700
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication is used to control blood pressure in patients with essential hypertension. It also helps reduce the risk of myocardial infarction, stroke, and death caused by cardiovascular diseases in patients aged 55 and older who have a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or high-risk diabetes. Therefore, this drug is effective not only for hypertension management but also for reducing the risk of major cardiovascular diseases. This treatment improves cardiovascular health and contributes to the patient maintaining a healthier lifestyle.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. When this drug is coadministered with thiazide diuretics such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at 80 mg once daily with water and may be taken regardless of meals. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment; the dose should not exceed 40 mg once daily.
This medication can cause serious harm, particularly to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be administered to individuals with allergies to this drug or its components, pregnant or breastfeeding women, individuals with severe liver dysfunction, patients with hereditary angioedema, and patients with certain kidney disorders. Care should be taken when prescribing this medication to the elderly, patients with hyperkalemia, liver disease, heart valve disorders, and ischemic heart disease, as there is the risk of excessively lowering blood pressure. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly monitored to detect and address adverse reactions early. Although this drug is effective in lowering blood pressure, it may rarely cause serious side effects such as angioedema, worsening kidney function, liver dysfunction, hyperkalemia, hypoglycemia, interstitial pneumonia, and rhabdomyolysis; if these symptoms appear, the physician should be informed immediately. Diabetic patients should observe for symptoms of hypoglycemia closely, and if angioedema symptoms (swelling of the face, lips, pharynx, or tongue) occur, the medication should be stopped immediately, and treatment should be sought. There may be interactions with other antihypertensive medications; thus, it is essential to inform the doctor or pharmacist about any other medications being taken. Patients undergoing hemodialysis or those with low sodium levels or blood volume are at risk of hypotension, so their condition should be corrected before administration, and they should be carefully monitored afterward. Women who are pregnant or planning to become pregnant should avoid using this medication, and breastfeeding women should either avoid this medication or discontinue breastfeeding. Safety and efficacy have not been established in children under 18 years; therefore, it is not recommended for this age group. Elderly patients should be cautious as excessive blood pressure lowering may increase the risk of stroke and other complications. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur; immediate medical attention should be sought for appropriate treatment. This medication should be stored out of the reach of children and kept sealed until used.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
White or off-white, oval, biconvex tablets
30 tablets (10 tablets/Alu-Alu × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.